Skip to content

Phase 1b study to assess the safety and tolerability of SR-878 in patients with rheumatoid arthritis

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-523678-17-00
Enrollment
12
Registered
2026-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis

Interventions

None listed

Sponsors

SciRhom GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Apr 25, 2026